This page in English

Maja Bradic

Anknuten

Besöksadress : Karolinska Universitetssjukhus ; Onkologiska Kliniken ; GI Mottagning, 171 76 Stockholm
Postadress : Institutionen för onkologi-patologi (OnkPat), K7, Forskargrupp Östman, Arne, Karolinska Universitetssjukhus ; Onkologiska Kliniken, 171 76 Stockholm
Leveransadress : Karolinska Universitetssjukhus ; Onkologiska Kliniken ; GI Mottagning, 171 76 Stockholm

Publikationer

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
Mezheyeuski A, Bradic Lindh M, Guren Tk, Dragomir A, Pfeiffer P, Kure Eh, et al
Oncotarget 2016;7(27):41948-41958

STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer
Peña C, Céspedes Mv, Lindh Mb, Kiflemariam S, Mezheyeuski A, Edqvist Ph, et al
Cancer research 2013;73(4):1287-97

Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells
Johansson Ac, Ansell A, Jerhammar F, Lindh Mb, Grénman R, Munck-wikland E, et al
Molecular cancer research : MCR 2012;10(9):1158-68

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, et al
Neuro-oncology 2011;13(11):1178-91

Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma
Paulsson J, Lindh Mb, Jarvius M, Puputti M, Nistér M, Nupponen Nn, et al
International journal of cancer 2011;128(8):1981-8

PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
Hägerstrand D, Lindh Mb, Peña C, Garcia-echeverria C, Nistér M, Hofmann F, et al
Neuro-oncology 2010;12(9):967-75